[An analysis of preliminary results in screening for prostatic cancer].
450 males aged over 50 years free of urological symptoms were screened for prostatic cancer using three techniques; finger rectal examination (FRE), transrectal ultrasound investigation (TUI), assay for prostatic specific antigen in the serum (SPSA). SPSA quantities under 4 ng/ml, 4-10 ng/ml, 10-20 ng/ml, over 20 ng/ml were registered in 206(45.8%), 135(30%), 69(15.4%) and 40(8.8%) patients, respectively. Detectability of prostatic cancer increases by 33,37.9, 45.5, 69.2% due to TUI, FRE, TUI + FRE, all the three methods, respectively. Prostatic biopsy was needed in 102 (22.7%) cases. From the 450 examinees, prostatic cancer was diagnosed in 25 (5.6%). SPSA was high in all of them, higher than 10 ng/ml in 92%. 20 (80%) of 25 patients with cancer had early stages of the disease (TI-2). The study is going on.
Matveev
B P
BP
Bukharkin
B V
BV
Komarova
L E
LE
Kadagidze
Z G
ZG
Sholokhov
V N
VN
Sokolov
A V
AV
Smirnov
A V
AV
Cheban
N L
NL
Perederiĭ
N V
NV
Lepédatu
P I
PI
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001706:Biopsy; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods* / Q000706:statistics & numerical data; D008875:Middle Aged; D010173:Palpation; D011467:Prostate / Q000000981:diagnostic imaging / Q000473:pathology; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000517:prevention & control*; D011472:Prostatitis / Q000175:diagnosis / Q000517:prevention & control; D012007:Rectum; D014463:Ultrasonography
D017430:Prostate-Specific Antigen
Analiz predvaritel'nykh rezul'tatov skrininga raka predstatel'noĭ zhelezy.